A. Vabø

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.

Kjell Arne Kvistad, Marit Muri Holmen, Per Skaane, 2007, Breast.

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

P. Møller, E. Hovig, L. Maehle, 2007, European journal of cancer.

High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series

P. Møller, L. Mæhle, L. F. Engebretsen, 2010, Hereditary cancer in clinical practice.

Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells

I. Sandlie, B. Bogen, L. Munthe, 1999, Nature Biotechnology.

Age‐specific incidence rates for breast cancer in carriers of BRCA1 mutations from Norway

P. Møller, L. Mæhle, P. Sun, 2013, Clinical genetics.

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

P. Møller, L. Mæhle, M. Holmen, 2014, Breast Cancer Research and Treatment.

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program

P. Møller, S. Narod, L. Mæhle, 2013, Breast Cancer Research and Treatment.